USFDA grants orphan drug status to mexiletine hydrochloride: Lupin

USFDA grants orphan drug status to mexiletine hydrochloride: Lupin The Mumbai-based company#39;s drug NaMuscula (mexiletine hydrochloride) is the first and only licensed product to treat myotonia in adults with non-dystrophic myotonic (NDM) disorders.

No comments:

Post a Comment